Atara Stock Analysis

ATRA -  USA Stock  

USD 13.99  0.32  2.24%

The small slip in market price for the last few months could raise concerns from investors as the firm it trading at a share price of 13.99 on 1,031,400 in volume. The company executives did not add much value to Atara Biotherap investors in December. However, diversifying your holdings with Atara Biotherap or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.06. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Atara Biotherap partners.
Please continue to Trending Equities.

Atara Stock Analysis 

The Atara Biotherap stock analysis report makes it easy to digest most publicly released information about Atara Biotherap and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Atara Stock analysis module also helps to analyze the Atara Biotherap price relationship with some important fundamental indicators such as market cap and management efficiency.

Atara Stock Analysis Notes

About 106.0% of the company shares are held by institutions such as insurance companies. The book value of Atara Biotherap was presently reported as 3.51. The company recorded a loss per share of 3.62. Atara Biotherap had not issued any dividends in recent years. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Atara Biotherap operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 578 people. For more info on Atara Biotherap please contact Pascal Touchon at 650 278-8930 or go to

Atara Biotherap Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Atara Biotherap's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Atara Biotherap or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Atara Biotherap generated a negative expected return over the last 90 days
Atara Biotherap has high historical volatility and very poor performance
The company reported the previous year's revenue of 12.79 M. Net Loss for the year was (328.1 M) with profit before overhead, payroll, taxes, and interest of 0.
Atara Biotherap currently holds about 357.24 M in cash with (190.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.04.
Atara Biotherap has a frail financial position based on the latest SEC disclosures
Latest headline from Developments in cell therapy boost potential for autoimmune disease treatments - The Science Board

Atara Biotherap Upcoming and Recent Events

Earnings reports are used by Atara Biotherap to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Atara Biotherap previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report7th of March 2022
Next Earnings Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End7th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Atara Largest EPS Surprises

Earnings surprises can significantly impact Atara Biotherap's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Atara Biotherap SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Atara Biotherap prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Atara Biotherap investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Atara Biotherap specific information freely available to individual and institutional investors to make a timely investment decision.
10th of January 2022
Financial Statements and Exhibits. Regulation FD Disclosure
7th of January 2022
Unclassified Corporate Event
21st of December 2021
Unclassified Corporate Event
26th of November 2021
Financial Statements and Exhibits. Other Events
4th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
4th of October 2021
Entry into a Material Definitive Agreement
10th of August 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
9th of August 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition

Atara Biotherap Thematic Classifications

In addition to having Atara Biotherap stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters IdeaCancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

Atara Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Atara Biotherap is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atara Biotherap backward and forwards among themselves. Atara Biotherap's institutional investor refers to the entity that pools money to purchase Atara Biotherap's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Hall Laurie J TrusteeCommon Shares340K
Baupost Group LlcCommon Shares8.5 M151.7 M
Jpmorgan Chase CoCommon SharesM143.5 M
Maverick Capital LtdCommon Shares7.9 M140.6 M
Blackrock IncCommon Shares7.7 M137 M
Vanguard Group IncCommon Shares6.8 M121.7 M
Redmile Group LlcCommon Shares6.5 M115.7 M
Note, although Atara Biotherap's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Atara Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atara Biotherap's market, we take the total number of its shares issued and multiply it by Atara Biotherap's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Atara Profitablity

Atara Biotherap's profitability indicators refer to fundamental financial ratios that showcase Atara Biotherap's ability to generate income relative to its revenue or operating costs. If, let's say, Atara Biotherap is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Atara Biotherap's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Atara Biotherap's profitability requires more research than a typical breakdown of Atara Biotherap's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.64) (0.69) 
Return on Average Equity(0.76) (0.78) 
Return on Invested Capital(0.93) (0.96) 

Management Efficiency

The entity has return on total asset (ROA) of (48.04) % which means that it has lost $48.04 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (98.81) %, meaning that it created substantial loss on money invested by shareholders. Atara Biotherap management efficiency ratios could be used to measure how well atara biotherap manages its routine affairs as well as how well it operates its assets and liabilities. As of January 23, 2022, Return on Average Assets is expected to decline to -0.69. In addition to that, Return on Average Equity is expected to decline to -0.78. Atara Biotherap Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 676.34 Million. The current year Current Assets is expected to grow to about 649.3 M, whereas Total Assets Per Share are forecasted to decline to 6.13.
Last ReportedProjected for 2022
Book Value per Share 7.19  7.84 
Enterprise Value over EBIT(5.75) (6.21) 
Enterprise Value over EBITDA(5.72) (6.17) 
Price to Book Value 2.97  2.97 
Tangible Assets Book Value per Share 7.16  10.49 
Enterprise Value1.7 B1.4 B
Tangible Asset Value676.3 M729.7 M

Technical Drivers

As of the 23rd of January, Atara Biotherap shows the risk adjusted performance of 1.0E-4, and Mean Deviation of 3.11. Atara Biotherap technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Atara Biotherap, which can be compared to its rivals. Please confirm Atara Biotherap jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Atara Biotherap is priced correctly, providing market reflects its regular price of 13.99 per share. Given that Atara Biotherap has jensen alpha of 0.0145, we suggest you to validate Atara Biotherap's prevailing market performance to make sure the company can sustain itself at a future point.

Atara Biotherap Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Atara Biotherap more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Atara Biotherap Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atara Biotherap insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atara Biotherap's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Atara Biotherap insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Atara Biotherap Predictive Daily Indicators

Atara Biotherap intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Atara Biotherap stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Atara Biotherap Forecast Models

Atara Biotherap time-series forecasting models is one of many Atara Biotherap's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Atara Biotherap's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Atara Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Atara Biotherap stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Atara shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Atara Biotherap. By using and applying Atara Stock analysis, traders can create a robust methodology for identifying Atara entry and exit points for their positions.
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Atara Biotherap operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 578 people.

Current Atara Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atara analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atara analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
27.5Strong Buy4Odds
Atara Biotherap current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Atara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Atara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Atara Biotherap, talking to its executives and customers, or listening to Atara conference calls.
Atara Analyst Advice Details

Atara Stock Analysis Indicators

Atara Biotherap stock analysis indicators help investors evaluate how Atara Biotherap stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Atara Biotherap shares will generate the highest return on investment. By understating and applying Atara Biotherap stock analysis, traders can identify Atara Biotherap position entry and exit signals to maximize returns.
Quick Ratio4.15
Fifty Two Week Low11.81
Shares Short Prior Month8.69M
Average Daily Volume Last 10 Day984.27k
Average Daily Volume In Three Month825.25k
Shares Percent Shares Out10.48%
Gross Margins-85.83%
Short Percent Of Float11.99%
Forward Price Earnings-4.14
Float Shares60.4M
Fifty Two Week High21.85
Enterprise Value To Ebitda-3.17
Fifty Day Average16.68
Two Hundred Day Average15.18
Enterprise Value To Revenue79.19
Please continue to Trending Equities. Note that the Atara Biotherap information on this page should be used as a complementary analysis to other Atara Biotherap's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Atara Stock analysis

When running Atara Biotherap price analysis, check to measure Atara Biotherap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherap is operating at the current time. Most of Atara Biotherap's value examination focuses on studying past and present price action to predict the probability of Atara Biotherap's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atara Biotherap's price. Additionally, you may evaluate how the addition of Atara Biotherap to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Atara Biotherap's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherap. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherap listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atara Biotherap is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherap's value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherap's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherap's market value can be influenced by many factors that don't directly affect Atara Biotherap's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherap's value and its price as these two are different measures arrived at by different means. Investors typically determine Atara Biotherap value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherap's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.